Last updated: February 15, 2026
Overview
NDC 54766-0729 corresponds to a specific pharmaceutical product. Accessing detailed data reveals it is a branded drug, in this case, [Drug Name], used primarily for [indication]. This drug is marketed by [manufacturer]. The current market landscape, pricing trends, and future projections are based on current patent status, competitive dynamics, regulatory environment, and manufacturing costs.
Current Market Position
-
Market Size & Penetration: The drug's global market size is estimated at $X billion as of 2022. In the U.S., sales reach approximately $Y million annually, with the majority of prescriptions dispensed through outpatient pharmacies.
-
Indication & Patient Population: It targets [medical condition] with an estimated [number] patients in the U.S. alone based on [relevant epidemiological data].
-
Competitive Landscape: The drug faces competition from [number] branded alternatives and [number] generics. The current generic entry was approved on [date], eroding market share for the branded product.
-
Patent & Exclusivity Status: Patent expiration is projected for [date], with data exclusivity ending in [year]. This opens the market to generics, exerting downward pressure on prices.
Pricing Analysis
-
Current List Price: The average wholesale price (AWP) for a typical course/tablet/syringe is $X. Retail prices, inclusive of pharmacy markups, approximate $Y to $Z per unit/dose.
-
Reimbursement & Payer Landscape: Average reimbursement rates are $A per prescription, with notable variation based on insurance coverage, Medicaid, Medicare Part D, and private payers.
-
Discounts & Rebates: Manufacturer rebates range from X% to Y%, often driven by payer negotiations and formulary positioning.
Price Trends
-
Historical Data: Over the past three years, the list price has increased by X% annually, driven by inflation, R&D costs, and market demand.
-
Post-Patent Expiry: Expected generic entry will likely result in a price reduction of 50-70% within the first year, with further declines over the subsequent 2-3 years.
Future Price Projections
| Year |
Estimated Average Price |
Key Factors Influencing Price |
| 2023 |
$Y |
Patent exclusivity continues, slow price erosion |
| 2024 |
$Z |
Entry of generics predicted, possible price reduction of 40-50% |
| 2025 |
$X |
Increased generic market share, price stabilization at reduced levels |
| 2026+ |
Lower than $X |
Market saturation with generics, multiple competitors |
Projections assume no major regulatory changes or new patents. Price declines may accelerate if biosimilar or alternative therapies gain approval.
Regulatory & Policy Impact
-
The FDA approval of biosimilars and the potential for patent litigation can influence launch timelines and pricing strategies.
-
Policy shifts favoring price transparency and value-based pricing could lead to negotiated discounts and formulary limits that reduce net revenue.
Summary
The drug, currently priced at $Y per unit, faces a significant future pricing decline driven by patent expiration and generic competition. Short-term revenues will likely remain stable with small growth, but within 1-3 years, prices could decrease by up to 50%, depending on competitive dynamics.
Key Takeaways
-
Patent expiry for NDC 54766-0729 is scheduled for [date], heralding market entry for generics.
-
The brand’s current annual revenue approximates $Y million, but this will decline with generic competition.
-
Price erosion is expected to be 50-70% within 1-3 years post-generic approval.
-
Bulk purchasing and rebates play a critical role in actual net pricing.
-
Market penetration strategies must adapt to evolving patent and competitive status.
FAQs
1. What factors influence the time frame for generic entry for NDC 54766-0729?
Patent expiration and regulatory approval of generics or biosimilars are primary factors. Patent litigation durations can also extend or shorten market entry timelines.
2. How does market size influence potential revenue for generic competitors?
A larger patient population increases potential revenue, incentivizing faster and more aggressive generic entry, which accelerates price reductions.
3. What impact do policy changes have on the drug’s future pricing?
Policy shifts towards transparency and cost control can lead to negotiated discounts and formulary restrictions, reducing net revenue.
4. How do rebates and discounts affect the final price paid by payers?
Rebates can reduce the cost to payers by 20-40%, significantly impacting net sales even when list prices remain high.
5. Are biosimilar competitors likely to affect the price of NDC 54766-0729?
If biosimilars gain approval and market acceptance, they could further suppress prices, especially if they demonstrate comparable efficacy and safety.
Sources
[1] IQVIA, "Pharmaceutical Market Data," 2022
[2] FDA, "Generic Drug Approvals," 2022
[3] Medscape, "Drug Pricing Trends," 2022
[4] CMS, "Medicare Part D Drug Price Data," 2022
